Bicyclic Pyridine Sirtuin Modulators for Selective Disease Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies lack effective solutions for modulating sirtuin proteins to treat a wide range of diseases related to aging, stress, diabetes, obesity, neurodegenerative disorders, and cardiovascular diseases, as existing treatments often have limited efficacy or significant side effects.
Innovation Solution
Development of novel sirtuin-modulating compounds that increase or decrease the activity of sirtuin proteins, administered alone or in combination with other therapeutic agents, to target specific diseases by enhancing mitochondrial activity, increasing muscle performance, or inducing apoptosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing therapies are used to treat diseases related to aging and stress, then treatment options are available, but efficacy is limited and side effects are significant
Solution Approach 1:
The patent modifies the chemical structure of sirtuin modulators by changing parameters such as introducing specific heterocyclic groups (pyridine, pyrimidine, triazine), adjusting substituent positions, and modifying molecular weight to optimize binding affinity and selectivity for sirtuin proteins, thereby improving efficacy while reducing side effects
Solution Approach 2:
The invention creates composite molecular structures combining multiple functional groups (e.g., bicyclic pyridine cores with various heterocyclic substituents) to achieve synergistic effects that enhance therapeutic activity and reduce adverse effects through multi-target modulation
2Duration of action of moving object
If sirtuin activity is increased to extend lifespan and improve healthspan, then therapeutic benefits are achieved, but control over specific disease targeting becomes challenging
Solution Approach 1:
The patent introduces tissue-specific targeting moieties and substituent patterns that confer different biological activities to specific compounds within the sirtuin modulator series, allowing selective activation of sirtuins in particular tissues (e.g., neural, cardiac, hepatic) to address disease-specific requirements while maintaining overall lifespan benefits
Solution Approach 2:
The invention divides the broad sirtuin modulation function into distinct sub-functions by creating multiple series of compounds with different core structures and substituent patterns, each tailored for specific disease indications, thereby enabling precise disease targeting while maintaining lifespan extension
Data Source
AI summary
Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.